- Home
- CLNN vs ANEB Comparison
CLNN vs ANEB Comparison
Compare CLNN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- ANEB
- Stock Information
- Founded
- CLNN 2012
- ANEB 2020
- Country
- CLNN United States
- ANEB United States
- Employees
- CLNN N/A
- ANEB N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- CLNN Health Care
- ANEB Health Care
- Exchange
- CLNN Nasdaq
- ANEB Nasdaq
- Market Cap
- CLNN 37.7M
- ANEB 36.7M
- IPO Year
- CLNN N/A
- ANEB 2021
- Fundamental
- Price
- CLNN $4.37
- ANEB $1.43
- Analyst Decision
- CLNN Strong Buy
- ANEB Buy
- Analyst Count
- CLNN 4
- ANEB 1
- Target Price
- CLNN $55.25
- ANEB $8.00
- AVG Volume (30 Days)
- CLNN 42.3K
- ANEB 25.7K
- Earning Date
- CLNN 05-07-2025
- ANEB 02-14-2025
- Dividend Yield
- CLNN N/A
- ANEB N/A
- EPS Growth
- CLNN N/A
- ANEB N/A
- EPS
- CLNN N/A
- ANEB N/A
- Revenue
- CLNN $421,000.00
- ANEB N/A
- Revenue This Year
- CLNN N/A
- ANEB N/A
- Revenue Next Year
- CLNN N/A
- ANEB N/A
- P/E Ratio
- CLNN N/A
- ANEB N/A
- Revenue Growth
- CLNN N/A
- ANEB N/A
- 52 Week Low
- CLNN $3.82
- ANEB $0.80
- 52 Week High
- CLNN $9.20
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- CLNN 45.51
- ANEB 58.07
- Support Level
- CLNN $4.25
- ANEB $0.91
- Resistance Level
- CLNN $4.60
- ANEB $1.70
- Average True Range (ATR)
- CLNN 0.32
- ANEB 0.19
- MACD
- CLNN 0.01
- ANEB 0.04
- Stochastic Oscillator
- CLNN 46.67
- ANEB 65.91
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.